Taiyo Holdings

Taiyo Holdings is a diversified Japanese corporation that has successfully expanded from its core electronics materials business into the pharmaceutical and life sciences sectors. The company operates in the healthcare space through two primary subsidiaries: Taiyo Pharma, which manages a portfolio of long-listed branded drugs, and Taiyo Pharma Tech, a comprehensive Contract Development and Manufacturing Organization (CDMO). Taiyo's pharmaceutical strategy focuses on the acquisition and stable supply of established medications from major Japanese firms like Chugai and Daiichi Sankyo. Their manufacturing capabilities include a wide range of formulations such as oral solids, injectables, and topicals, all produced under strict GMP standards. By leveraging its industrial expertise, Taiyo Holdings aims to provide a reliable infrastructure for the healthcare industry while maintaining its global leadership in electronics chemicals.